Skip to main content
. 2024 Jan 13;23:29. doi: 10.1186/s12933-023-02105-x

Table 1.

Baseline characteristics grouped according to SHR levels

Variables Total Groups (group 1–7) divided by SHR P value
< 0.50 0.50–0.74 0.75–0.99 1.00–1.24 1.25–1.49 1.50–1.74 ≥ 1.75
Sample, % 8268 (100) 286 (3.5) 1018 (12.3) 2854 (34.5) 1904 (23.0) 996 (12.0) 530 (6.4) 680 (8.2)
Age, year 72.4 (62.9–81.5) 68.1 (58.2–76.1) 72.3 (62.5–81.4) 73.3 (63.3–82.1) 72.8 (63.4–41.7) 72.9 (63.6–82.2) 72.1 (65.1–80.1) 70.5 (61.2–79.4) < 0.001
Male, % 4665 (56.4) 163 (57.0) 579 (56.9) 1646 (57. 7) 1079 (56. 7) 535 (53.7) 281 (53.0) 382 (56.2) 0.279
Vital Signs
 SBP, mmHg 114 (106–127) 116 (106–131) 114(105–126) 114 (1056 − 125) 115 (106–126) 115(106–129) 115 (107–128) 115 (106–128) 0.121
 Heart rate, bpm 82 (73–92) 81 (71–91) 81(72–91) 81 (72–90) 82 (73–92) 83 (74–93 85 (76–95) 84 (73–94) < 0.001
 Temperature, ℃ 36.7 (36.5–37.0) 36.7 (36.4–36.9) 36.7 (36.5–36.9) 36.7 (36.5–37.0) 36.7 (36.5–37.0) 36.8 (36.6–37.0) 36.8 (36.6–37.0) 36.8 (36.6–37.0) < 0.001
 RR, bpm 19 (17–21) 18 (16–20) 18 (17–21) 19 (17–21) 19 (17–22) 19 (17–22) 19 (17–22) 20 (17–22) < 0.001
Comorbidities
 Acute HF, % 5564 (67.3) 205 (71.7) 708 (69.6) 1787 (62.6) 1281 (67.3) 703 (70.6) 382 (72.1) 498 (73.2) < 0.001
 Hypertension,% 5708 (69.0) 195 (68.2) 726 (71.3) 1974 (69.2) 1323 (69.5) 668 (67.1) 369 (69.6) 453 (66.6) 0.367
 AF, % 4669 (56.5) 148 (51.8) 589 (57.9) 1681 (58.9) 1078 (56.6) 537 (53.9) 295 (55.7) 341 (50.2) < 0.001
 AMI, % 1823 (22.1) 63 (22.0) 207 (20.3) 491 (17.2) 422 (22.2) 253 (25.4) 160 (30.2) 227 (33.4) < 0.001
 OMI, % 2518 (30.5) 108 (37.8) 325 (31.9) 815 (28.6) 557 (29.3) 299 (30.0) 182 (34.3) 232 (34.1) < 0.001
 NICM, % 1171 (14.16) 42 (14.7) 166 (16.3) 383 (13.4) 249 (13.1) 141 (14.2 79 (14.9) 111 (16.3) 0.129
 T2DM, % 4687 (56.7) 272 (95.1) 703 (69.1) 1252 (43.9) 970 (51.0) 596 (60.0) 374 (70.6) 520 (76.5) < 0.001
 Stroke, % 2764 (33.4) 90 (31.5) 344 (33.8) 969 (33.9) 625 (32.8) 340 (34.1) 167 (31.5) 229 (33.7) 0.886
 CKD, % 4211 (50.9) 228 (79.7) 598 (58.7) 1326 (46.5) 899 (47.2) 472 (47.4) 286 (54.0) 402 (59.1) < 0.001
Laboratory tests
 NT-pro BNP, pg/mL

2482

(821–6745)

3061

(922-10085)

2465

(787–6743)

2538

(874–6712)

2372

(833–6138)

2464

(834–7020)

2424

(720–7906)

2575

(750–7428)

0.490
 SCr, mg/dL 1.1 (0.8–1.5) 1.30 (0.9–2.1) 1.1 (0.9–1.6) 1.1 (0.8–1.4) 1.1 (0.8–1.4) 1.1 (0.8–1.5) 1.1 (0.9–1.6) 1.3 (0.9–1.8) < 0.001
 BUN, mg/dL 21 (15–32) 25 (17–39) 22 (15–33) 20 (15–30) 21 (15–31) 21 (15–32) 23 (16–35) 25 (17–39) < 0.001
 Glucose, mg/dL 128 (103–176) 75 (60–97) 94 (83–116) 108 (98–124) 136 (121–160) 171 (149–206) 211 (183–254) 303 (246–382) < 0.001
 HbA1c, % 6.1 (5.6-7.0) 8.6 (7.2–10.6) 6.6 (6.0–8.0) 5.9 (5.6–6.5) 5.9 (5.5–6.7) 6.0 (5.5–6.9) 6.2 (5.6–7.1) 6.4 (5.7–7.4) < 0.001
Medical History
 Insulin use, % 3445 (41.7) 222 (77.6) 546 (53.6) 931 (32.6) 697 (36.6) 419 (42.1) 260 (49.1) 370 (54.4) < 0.001
 LD use, % 7565 (91.5) 266 (93.0) 944 (92.7) 2631 (92.2) 1728 (90.8) 905 (90.9) 482 (90.9) 609 (89.6) 0.128
  Vasopressor, % 3632 (43.9) 111 (38.8) 429 (42.1) 1324 (46.4) 801 (42.1) 442 (44.4) 220 (41.5) 305 (44.9) 0.016
  MV, % 6741 (81.5) 222 (77.6) 806 (79.2) 2331 (81.7) 1557 (81.8) 829 (83.2) 434 (81.9) 562 (82.7) 0.158
 RRT 1st 24 h, % 491 (5.9) 45 (15.7) 71 (7.0) 125 (4.4) 102 (5.4) 50 (5.0) 40 (7.6) 58 (8.5) < 0.001

SHR: stress hyperglycemia ratio; SBP: systolic blood pressure; RR: respiratory rate; HF: heart failure; AF: atrial fibrillation; AMI: acute myocardial infarction; OMI: old myocardial infarction; NICM: non-ischemic cardiomyopathy; T2DM: type 2 diabetes mellitus; CKD: chronic kidney injury; Nt-pro BNP: N-terminal forebrain natriuretic peptide; SCr: serum creatinine; BUN: blood urea nitrogen; HbA1c: glycosylated hemoglobin A1c; LD: loop diuretics; MV: mechanical ventilation; RRT: renal replacement treatment